Introduction {#s1}
============

Epilepsy is a network phenomenon in which changes in excitability, inhibitory tone, and/or excitation/inhibition balance play a major role. Accordingly, monogenic epilepsies have widely been associated with mutations in voltage- and ligand-gated channels that cause changes in neuronal network excitability ([@BHU141C59]). In addition, several genes encoding presynaptic proteins are associated with epilepsy in both humans and mice. *STXBP1*, a gene encoding Munc18-1, a presynaptic protein that modulates neurotransmitter release, is mutated in Ohtahara syndrome---early infantile epileptic encephalopathy (IEEE; [@BHU141C61]; [@BHU141C48]). *STXBP1* is also linked with the West syndrome ([@BHU141C55]) and non-syndromic epilepsy with mental retardation ([@BHU141C34]). Compound mutations of *NRXN1*, encoding the presynaptic protein neurexin, are associated with severe early-onset epilepsy ([@BHU141C35]). SV2A, a synaptic vesicle (SV) protein that regulates presynaptic Ca^2+^ and SV exocytosis ([@BHU141C70]), binds the antiepileptic drug levetiracetam ([@BHU141C44]). Epileptic patients show reduced levels of SV2A in their brain ([@BHU141C25]), and SV2A^−/−^ mice experience severe seizures and die within 3 weeks ([@BHU141C17]).

Recently, mutations in human *SYN1/2* genes encoding synapsins (Syns) I and II, members of a family of SV phosphoproteins that regulate synaptic transmission and plasticity at inhibitory and excitatory synapses ([@BHU141C12]), have been implicated in epilepsy. Non- and missense mutations in *SYN1* were identified as the causes of epilepsy and/or autism in several studies ([@BHU141C28]; [@BHU141C24]; [@BHU141C43]). In addition, genetic mapping analysis identified variations or non-/missense mutations in *SYN2* as significantly contributing to epilepsy and autism predisposition ([@BHU141C11]; [@BHU141C40]; [@BHU141C14]). Mice lacking Syn I, Syn II, Syn I/II, or Syn I/II/III develop seizures starting at 2---3 months of age ([@BHU141C42]; [@BHU141C60]; [@BHU141C30]), with Syn II deletion producing the most severe phenotype ([@BHU141C15]; [@BHU141C19]; [@BHU141C33]). Alterations in inhibition underlie many animal models of epilepsy ([@BHU141C2]; [@BHU141C57]) and the deletion of Syns in mice severely impairs inhibitory transmission ([@BHU141C30]; [@BHU141C4]; [@BHU141C12]).

We recently showed that the deletion of Syn II is associated with a specific loss of asynchronous GABA release at inhibitory synapses, and that the desynchronizing action of Syn II is mediated by an interaction with P-/Q-type Ca^2+^ channels ([@BHU141C47]). Here, we investigate how changes in the dynamics of GABA release may lead to hyperexcitability and how this state can be targeted by specific therapeutic strategies. We demonstrate that: (1) the lack of asynchronous GABA release in SynII^−/−^ mice causes a reduction in tonic inhibition that results in hyperexcitability and epileptogenesis and (2) rescuing tonic inhibition by agonists of extrasynaptic GABA~A~ receptors reverts the epileptic phenotype both in vitro and in vivo.

Materials and Methods {#s2}
=====================

Experimental Animals {#s2a}
--------------------

Syn II knockout (Syn II^−/−^) mice were generated by homologous recombination and extensively backcrossed on a C57BL/6J background (Charles River, Calco, Italy) for over 10 generations. Experiments were performed on 4- to 8-month-old epileptic Syn II^−/−^ male mice and age-matched C57BL/6J wild-type (WT) animals. All experiments were carried out in accordance with the guidelines established by the European Communities Council (Directive 2010/63/EU of 22 September 2010) and were approved by the Italian Ministry of Health.

Preparation of Slices {#s2b}
---------------------

After anesthesia with isofluorane, horizontal hippocampal slices (400-μm thickness) from WT and Syn II^−/−^ mice were cut using a Microm HM 650V microtome equipped with a Microm CU 65 cooling unit (Thermo Fisher Scientific, Waltham, MA, USA) at 2--4 °C in a solution containing (in mM): 87 NaCl, 25 NaHCO~3~, 2.5 KCl, 0.5 CaCl~2~, 7 MgCl~2~, 25 glucose, 75 sucrose, and saturated with 95% O~2~ and 5% CO~2~. After cutting, we let the slices recover for 1 h at 35 °C and for another 2 h at room temperature in recording solution.

Patch-Clamp Recordings {#s2c}
----------------------

Whole-cell, patch-clamp recordings from dentate gyrus (DG) granule neurons in acute hippocampal mice slices were performed as previously described ([@BHU141C47]). Recordings were performed with a Multiclamp 700B/Digidata1440A system (Molecular Devices, Sunnyvale, CA, USA) on visually identified DG cells using an upright BX51WI microscope (Olympus, Tokyo, Japan). We recorded mature DG neurons in which *R*~m~ \< 300 MΩ. The extracellular solution used for the recordings contained (in mM): 125 NaCl, 25 NaHCO~3~, 25 glucose, 2.5 KCl, 1.25 NaH~2~PO~4~, 2 CaCl~2~, and 1 MgCl~2~ (bubbled with 95% O~2~ and 5% CO~2~). In some experiments, CaCl~2~ was replaced with an equimolar concentration of SrCl~2~. For tonic inhibition and spontaneous inhibitory postsynaptic current (sIPSC) recordings, experiments were performed at a holding potential (*V*~h~) of −80 mV in the presence of 50 μM D-(2R)-amino-5-phosphonovaleric acid (D-APV), 10 μM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), and 5 μM CGP 55845 (all from Tocris Bioscience, Ellisville, MO, USA) using a high-chloride intracellular solution containing (in mM): 126 KCl, 4 NaCl, 1 MgSO~4~, 0.02 CaCl~2~, 0.1 BAPTA, 15 glucose, 5 HEPES, 3 ATP, and 0.1 GTP in which the pH was adjusted to 7.3 with KOH and osmolarity was adjusted to 290 mOsmol/L with sucrose. For current-clamp experiments, the internal solution contained (in mM): 126 K gluconate, 4 NaCl, 1 MgSO~4~, 0.02 CaCl~2~, 0.1 BAPTA, 15 glucose, 5 HEPES, 3 ATP, 0.1 GTP, and pH 7.3. Only cells with resting membrane potential between −70 and −85 mV were considered for analysis. Somatic access resistance was monitored continuously, and cells with unstable access resistance (20% changes) or with values \>15 MΩ were excluded from analysis.

All patch-clamp data were acquired with Clampex 10.2 and analyzed offline with Clampfit 10.2 (pClamp, Molecular Devices) and MiniAnalysis (Synaptosoft, Decatur, GA, USA). The analysis of *sIPSCs*, *Aps*, and *delayed asynchronous release* was performed as previously described ([@BHU141C47]). For the calculation of the *tonic current*, 0.5-ms bin histograms of the baseline before and after its shift were constructed and fitted with a single Gaussian. From the fit value, the total tonic current was considered as the reduction in the baseline current after bath addition of 30 μM bicuculline ([@BHU141C31]). Neurons were voltage-clamped at −80 mV, and 1 μM (4,5,6,7-tetrahydroisoxazolo\[5,4-c\]pyridin-3-ol; gaboxadol) THIP or 10 μM NO-711 (Tocris Bioscience) was added via bath perfusion.

High-Density Active-Pixel Sensor Recordings {#s2d}
-------------------------------------------

The Active Pixel Sensor Multielectrode Array (APS-MEA) system was extensively characterized in our previous paper ([@BHU141C27]). The chip integrates amplification and analog multiplexing circuits designed to provide simultaneous extracellular recordings from 4096 electrodes at a sampling rate of 7.7 kHz per channel. Each square pixel measures 21 × 21 μm, and the array is integrated with an electrode pitch (center-to-center) of 42 μm. Pixels are arranged in a 64 × 64 array configuration, yielding an active area of 7.22 mm^2^ with a pixel density of 567 pixel/mm^2^. Three on-chip amplification stages provide a global gain of 60 dB, with a 0.1- to 5-kHz band-pass filter. This bandwidth is adapted to record both slow local field potential (LFP) signals and fast action potentials (APs). Acquisition was controlled using the BrainWave software (3Brain GmbH, Switzerland).

Epileptiform activity was recorded in acute cortico-hippocampal slices in 20 min sessions (once activity had stabilized for at least 30 min). Spontaneous LFPs, in the form of interictal (I-IC) and ictal (IC) in vitro events, were elicited by bath application of 100 μM 4-aminopyridine (4-AP). IC and I-IC events were detected with a previously described Precision Timing Spike Detection (PTSD) algorithm ([@BHU141C45]). The algorithm, originally tailored to detect fast-spiking activity generated by a few neuronal units, has been adapted to detect slower field potential events. To this purpose, the threshold was set to 5-fold the standard deviation of the noise, whereas the refractory period and the peak lifetime period were set to 50 and 40 ms, respectively. The number of I-IC events was then manually extracted by looking at the raster plot from the whole array.

Activated areas during IC activity for all the experimental conditions were calculated by counting the number of electrodes that, upon detection of the oscillation in the IC events, showed a firing rate within 0.005 and 3 Hz (to eliminate noisy channels). All the analysis algorithms were developed as Matlab scripts (MathWorks, <http://www.mathworks.it/>), with the exception of the I-IC and IC event detection that was implemented in C\# language under Visual Studio (<http://www.microsoft.com/visualstudio/en-gb>).

Treatment and Seizure Experiments {#s2e}
---------------------------------

ALZET-1002 osmotic minipumps, filled with THIP (2.5 mg/kg) or vehicle (artificial cerebrospinal fluid (ACSF)), were implanted subcutaneously to achieve a 1-week continuous treatment with THIP. The THIP dose was equivalent to an initial cerebral concentration of 0.5--1 μM ([@BHU141C16]). Systematic induction of seizures was performed as previously described ([@BHU141C19]) before the treatment (pre-treatment trial), at the second and seventh day of treatment and 6 weeks after. Seizure provocations consisted of moving the animal from its cage to an adjacent cage. All provocations were recorded on tape with a digital video camera (Panasonic NV-GS180, Tokyo, Japan) angled 45° from above to optimize animal behavior classification. Filmed provocations were later streamed to a personal computer (PC) for digital storage and visually analyzed. Seizure activity was scored using a previously described seizure rating scale for mice ([@BHU141C52]). Briefly, behavioral feature characteristics of seizures were assessed based on the video recordings as follows: 0 normal behavior; 1 immobility; 2 rigid posture; 3 repetitive scratching, circling, or head bobbing; 4 forelimb clonus, rearing, and falling; 5 level-4 behavior repeated; 6 severe tonic--clonic seizures; and 7 death.

Open Field {#s2f}
----------

Exploratory activity in a novel environment was assessed by a 10-min session in an open field chamber (44 cm L × 44 cm W × 44 cm H) constructed of gray Plexiglas. Locomotor activity in the central and external part of open field was measured by a video camera and analyzed using the ANYmaze program (Ugo Basile, Varese, Italy).

Statistical Analysis {#s2g}
--------------------

All data are expressed as mean ± SEM. For comparison between WT and Syn II^−/−^ experiments, either the unpaired/paired Student\'s *t*-test or the Mann--Whitney *U*-test was used (whenever the distribution of data fell from normality, as tested with an *F*-test to compare variances). For multiple comparisons, one-/two-way analysis of variance (ANOVA) was used, followed by the appropriate post hoc test. The level of significance was set at *P* \< 0.05.

Results {#s3}
=======

Loss of Asynchronous GABA Release Leads to Cellular Hyperexcitability {#s3a}
---------------------------------------------------------------------

We have recently shown that the Syn II deletion in mice leads to an increase in synchronous release and an almost complete loss of asynchronous GABA release in the DG granule neurons ([@BHU141C47]). We further investigated the frequency-dependence and the consequences of this defect in Syn II^−/−^ acute hippocampal slices. We found that, in WT slices, the proportion of delayed asynchronous release is relatively small in response to single stimuli or to low stimulation frequencies (e.g., 10 Hz, not shown), while it strongly increases at higher frequencies (e.g., 40 Hz; Fig. [1](#BHU141F1){ref-type="fig"}*a*,*b*). This effect is due to the fact that the stimulus-locked phasic asynchronous GABA release replaces synchronous release due to the intraterminal Ca^2+^ build-up ([@BHU141C56]) when inhibitory synapses are repeatedly activated. On the contrary, in inhibitory synapses on granule neurons from Syn II^−/−^ adult symptomatic mice, the delayed asynchronous release was almost completely missing and virtually unresponsive to the stimulation frequency (Fig. [1](#BHU141F1){ref-type="fig"}*a*,*b*). Figure 1.Asynchronous GABA release induced by high-frequency stimulation is lacking in the DG of Syn II^−/−^ mice. (*a* and *b*) Example of a delayed asynchronous inhibitory response in DG granule neurons after a 40-Hz train (*a*) and (*b*) its mean values at various stimulation frequencies (0.1 Hz, 10 and 40 Hz for 2 s). WT slices respond to the highest stimulation frequency with a marked increase in asynchronous GABA release, while Syn II^−/−^ slices are virtually unresponsive. \*\*\**P* \< 0.001, two-tailed unpaired Student\'s *t*-test. (*c*) Representative responses of WT and Syn II^−/−^ DG neurons to 100 pA/1 s injected current ramps and (*d*) histograms of mean firing rate, input resistance, and firing threshold of WT (black) and Syn II^−/−^ (gray) DG neurons. WT: *n* = 10 neurons; Syn II^−/−^: *n* = 5 neurons. \**P* \< 0.05; \*\*\**P* \< 0.001, two-tailed Mann--Whitney *U*-test. (*e*--*g*) Effects of 40 Hz stimulation. Representative traces (*e*) and correlation plot (*f*) between the delayed asynchronous inhibitory response and the reduction in firing observed after the 40-Hz stimulation (WT: black; Syn II^−/−^: gray). (*g*) The delayed asynchronous inhibitory release induced by the train reduced AP firing (left) and *R*~in~ (middle) in WT slices (black), but not in Syn II^−/−^ slices (gray) in response to 100 pA injected current, in the absence of significant effects on AP threshold (right). Upper row, absolute values; lower row, normalized values. \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001, one-way ANOVA for repeated measures followed by the Dunnett\'s post hoc test.

To show the physiological importance of asynchronous GABA release in the regulation of excitability of target cells, we performed single and repetitive stimulations of the perforant path and analyzed the firing patterns of postsynaptic granule neurons in the current-clamp, whole-cell configuration. Granule neurons were depolarized by a 100-pA ramp lasting 1 s before and 100 ms after the extracellular stimulation of the perforant path axons with a single stimulus or at various times (0.1, 5, 10, and 30 s) after a 2-s stimulation train at 10 or 40 Hz (Fig. [1](#BHU141F1){ref-type="fig"}*c*--*e*). The initial firing frequency evoked by the depolarizing ramp before the perforant path stimulation was significantly higher in the DG neurons from Syn II^−/−^ slices (4.53 ± 0.24 Hz, *n* = 9 in WT slices vs. 7.56 ± 0.77 Hz, *n* = 5 in Syn II^−/−^ slices; *P* = 0.003, two-tailed Mann--Whitney *U*-test) and was accompanied by an increase in the input resistance (*R*~in~), with no changes in the AP voltage threshold (Fig. [1](#BHU141F1){ref-type="fig"}*c*,*d*). Neither single stimuli, nor a 10-Hz train, did significantly modify the ramp-evoked firing frequency, *R*~in~ and AP voltage threshold in WT or Syn II^−/−^ neurons consistent with the minimal amount of asynchronous GABA release induced by the stimulation (data not shown). However, stimulation with the 40-Hz train reduced the AP frequency in the ramp immediately following the train by 37.22 ± 6.51% in WT neurons, while it was totally ineffective in Syn II^−/−^ neurons (Fig. [1](#BHU141F1){ref-type="fig"}*e*). The reduction in AP frequency observed after the 40-Hz train in WT slices persisted also during the ramps administered at 5 s (25.71 ± 6.22%) and 10 s (18.33 ± 8.9%), but not during the ramp injected at 30 s (0.1 ± 10.1%) after the stimulation train (Fig. [1](#BHU141F1){ref-type="fig"}*e*,*g*), a time frame in close agreement with the decay of the delayed asynchronous release induced by the train (Fig. [1](#BHU141F1){ref-type="fig"}). Moreover, the amount of asynchronous GABA release following the 40-Hz train in WT slices was significantly correlated with the observed reduction in the firing frequency (Pearson\'s *r* = 0.672, *P* = 0.004; Fig. [1](#BHU141F1){ref-type="fig"}*f*). Interestingly, the sustained decrease in AP frequency observed in WT slices was paralleled by a similar reduction in the *R*~in~ that was virtually absent in Syn II^−/−^ slices (Fig. [1](#BHU141F1){ref-type="fig"}*g*). No changes in AP voltage threshold were observed in either genotype and under all experimental conditions (Fig. [1](#BHU141F1){ref-type="fig"}*e*,*g*). The data suggest that asynchronous GABA release has a protective role on the postsynaptic cell firing by increasing the duration of inhibition in a manner directly correlated with the presynaptic stimulation frequency.

The Strong Impairment of Asynchronous GABA Release in Syn II^−/−^ Mice Leads to a Complete Loss of Tonic Inhibition {#s3b}
-------------------------------------------------------------------------------------------------------------------

Inhibition mediated by GABA release can be phasic or tonic depending on the postsynaptic receptors that are activated. Our next question was to directly investigate both components of inhibition in the DG neurons of SynII^−/−^ mice. The tonic inhibitory current, measured as the baseline offset following the addition of 30 μM bicuculline, was virtually absent in Syn II^−/−^ DG granule neurons (34.22 ± 6.76 pA, *n* = 8 in WT slices vs. 4.82 ± 1.27 pA, *n* = 6 in Syn II^−/−^ slices; *P* = 0.0007, two-tailed Mann--Whitney *U*-test) (Fig. [2](#BHU141F2){ref-type="fig"}*a*), while no difference was detected between genotypes on phasic inhibitory current (Fig. [2](#BHU141F2){ref-type="fig"}*c*,*d*). The current hypothesis behind tonic inhibition proposes that the spillover of GABA from the synaptic cleft results in the activation of extrasynaptic GABA~A~ receptors localized a few micrometers away from the synapse and displaying high affinity for GABA ([@BHU141C53]; [@BHU141C23]). In the DG granule cells, tonic inhibition is exclusively mediated by extrasynaptic GABA receptors containing the δ subunit ([@BHU141C53]). To investigate whether the expression of these receptors was altered in Syn II^−/−^ mice, we used gaboxadol (THIP), a selective agonist for δ subunit-containing extrasynaptic GABA~A~ receptors that induce a tonic conductance in DG granule neurons ([@BHU141C68]). Indeed, addition of THIP (1 μM) induced an inhibitory tonic current in the Syn II^−/−^ neurons equal to the one induced in WT slices (36.00 ± 10.53 pA, *n* = 8 in WT slices vs. 34.57 ± 9.27 pA, *n* = 8 in Syn II^−/−^ slices; *P* = 0.200, two-tailed Mann--Whitney *U*-test) (Fig. [2](#BHU141F2){ref-type="fig"}*b*), in the absence of detectable effects on the phasic inhibitory current (Fig. [2](#BHU141F2){ref-type="fig"}*c*,*d*). These results suggest that: (1) the loss of tonic inhibition in Syn II^−/−^ mice is not due to impairments of the postsynaptic site, but to dysfunctions of presynaptic GABA release and (2) tonic inhibition seems to be predominantly caused by the asynchronous component of GABA release. Figure 2.Tonic inhibition is specifically lost in the DG of Syn II^−/−^ mice and can be rescued upon stimulation of extrasynaptic GABA~A~ receptors. (*a*) Representative traces of tonic inhibitory currents in WT and Syn II^−/−^ DG granule neurons (left) and the respective histogram showing the complete loss of tonic inhibition in acute slices from Syn II^−/−^ mice (WT: black; Syn II^−/−^: gray). (*b*) Rescue of the tonic inhibitory current in the Syn II^−/−^ DG to WT levels by the δ-subunit GABA~A~ agonist THIP (1 μM). Representative traces of tonic inhibitory currents in WT and Syn II^−/−^ DG granule neurons treated with THIP (left) and the respective histogram are shown. Each dot represents an individual neuron. (*c*) Representative traces of spontaneous inhibitory PSCs recorded in DG granule neurons from WT (black) and Syn II^−/−^ (gray) mice before and after bath application of 1 μM THIP. (*d*) The results of paired experiments show that no changes in the main sIPSC parameters such as amplitude, frequency, rise time, and decay constant occur after the addition of THIP in both genotypes, consistent with the exclusive extrasynaptic expression of GABA~A~ receptors containing the δ-subunit for which THIP is an agonist. \*\*\**P* \< 0.001, Two-tailed paired Student\'s *t*-test was used for statistics. *n* = 6 neurons/genotype.

To address the question of whether asynchronous GABA release is indeed the major determinant of the tonic inhibitory current, we used a pharmacological approach to rescue asynchronous release in Syn II^−/−^ mice and test for the parallel recovery of tonic inhibition. First, blockade of the GABA transporter 1 (GAT-1) with NO-711 (10 μM), which inhibits GABA removal from the synaptic cleft, restored the tonic GABA current in Syn II^−/−^ slices to values similar to those observed in WT slices (42.23 ± 3.91 pA, *n* = 8 in WT slices vs. 52.95 ± 6.95 pA, *n* = 8 in Syn II^−/−^ slices; *P* = 0.878, two-tailed Mann--Whitney *U*-test) (Fig. [3](#BHU141F3){ref-type="fig"}*a*), strongly suggesting that an impairment of GABA release/spillover is indeed responsible for the loss of tonic inhibition observed in the DG of Syn II^−/−^ mice. Figure 3.Tonic inhibition in the DG of Syn II^−/−^ mice is fully recovered by inhibition of GABA uptake or by rescuing asynchronous release. (*a*) Representative traces (left) of tonic inhibitory currents in WT and Syn II^−/−^ DG granule neurons in the presence of the GAT-1 blocker NO-711 (10 μM) and the respective histograms (right) showing the recovery of tonic inhibition in Syn II^−/−^. (*b*) Desynchronization of GABA release by extracellular Sr^2+^ rescues tonic inhibition in the DG of Syn II^−/−^ mice. Representative traces (left) of tonic inhibitory currents in WT and Syn II^−/−^ DG granule neurons and the respective histograms (right) showing that tonic inhibition is rescued in Syn II^−/−^ slices when extracellular Ca^2+^ is replaced with an equimolar concentration of Sr^2+^. Each dot represents an individual neuron.

Next, we attempted to directly demonstrate the functional link between the loss of asynchronous release and the loss of tonic inhibition. To this aim, we desynchronized GABA release by replacing extracellular Ca^2+^ with an equimolar concentration of Sr^2+^, which displays a similar affinity for the distinct presynaptic Ca^2+^ sensors responsible for synchronous and asynchronous release ([@BHU141C32]; [@BHU141C1]; [@BHU141C71], [@BHU141C72]). This experimental maneuver was previously demonstrated to partially rescue the delayed asynchronous GABA release in SynII^−/−^ DG neurons ([@BHU141C47]). In the presence of Sr^2+^, the tonic inhibitory current measured in Syn II^−/−^ slices, virtually absent under control conditions, returned to levels similar to those in WT slices (36.25 ± 7.96 pA *n* = 6 in WT slices vs. 27.38 ± 5.37 *n* = 5 in Syn II^−/−^ slices, *P* = 0.404, two-tailed Mann--Whitney *U*-test) (Fig. [3](#BHU141F3){ref-type="fig"}*b*; cfr. with Fig. [2](#BHU141F2){ref-type="fig"}*a*). These results demonstrate a direct link between the dynamics of presynaptic GABA release and extrasynaptic tonic inhibition.

Rescue of Tonic Inhibition by THIP Decreases the Hyperexcitability of DG Granule Neurons in Syn II^−/−^ Mice {#s3c}
------------------------------------------------------------------------------------------------------------

If the hyperexcitability of Syn II^−/−^ mice is indeed due to the specific loss of tonic inhibition due to the altered release dynamics, then boosting tonic inhibition in Syn II^−/−^ cortico-hippocampal slices should rescue hyperexcitablity at both single granule cell and entire network levels. To this aim, we chose THIP that specifically enhances the activity of δ-containing GABA~A~ receptors expressed in granule cells and, partially, in the CA1 pyramidal cells ([@BHU141C63]) and is more specific to the hippocampus than NO-711 or Sr^2+^ that have ubiquitous synaptic action. Current-clamp experiments showed that, consistent with a lack of tonic inhibition ([@BHU141C50]), the AP firing rate of Syn II^−/−^ granule neurons was increased (at 200 pA injected current: WT: 8.76 ± 1.4 Hz; Syn II^−/−^: 14.47 ± 1.9 Hz; *n* = 17 slices/genotype; *P* = 0.011, vehicle across genotype, two-way ANOVA followed by the Bonferroni\'s post hoc test). Such increased firing was normalized by the addition of THIP (1 μM) that was virtually ineffective in WT neurons (WT + THIP: 6.42 ± 1.3 Hz, *P* = 0.414 vs. vehicle within genotype; Syn II^−/−^ + THIP: 7.62 ± 1.7 Hz, *P* = 0.006 vs. vehicle within genotype; *P* = 0.603, THIP effect across genotype, two-way ANOVA followed by the Bonferroni\'s post hoc test) (Fig. [4](#BHU141F4){ref-type="fig"}*a*--*c*). Figure 4.THIP rescues Syn II^−/−^ DG granule neurons from hyperexcitability. (*a*) Whole-cell, current-clamp recordings from WT (black) and Syn II^−/−^ (gray) showing AP firing upon injection of 200 pA before and after the addition of 1 μM THIP. (*b* and *c*) Mean frequency--current plot (*b*) and histogram (*c*) depicting the increased excitability of Syn II^−/−^ DG granule neurons and its normalization in response to the application of 1 μM THIP. (*d* and *e*) The analysis of membrane potential and input resistance shows that the addition of 1 μM THIP brings both the depolarized membrane potential (*d*) and the increased input resistance (*e*) of Syn II^−/−^ DG granule neurons to WT levels. \**P* \< 0.05, \*\**P* \< 0.01 across genotype; ^+^*P* \< 0.05, ^++^*P* \< 0.01, effect of treatment within genotype; two-way ANOVA followed by the Bonferroni\'s post hoc test.

The analysis of the passive neuronal parameters showed that the increased firing rate of the Syn II^−/−^ granule neurons was due both to a more depolarized membrane potential (WT: −78.83 ± 0.6 mV, *n* = 26 slices; Syn II^−/−^: −76.23 ± 0.9 mV, *n* = 22 slices; *P* = 0.023, vehicle across genotype; two-way ANOVA followed by the Bonferroni\'s post hoc test) and to an increased membrane resistance (WT: 0.267 ± 0.01 GΩ, *n* = 26 slices; Syn II^−/−^: 0.323 ± 0.01 GΩ, *n* = 22 slices; *P* = 0.010, vehicle across genotype; two-way ANOVA followed by the Bonferroni\'s post hoc test). The addition of THIP normalized both the depolarized membrane potential and the increased input resistance of Syn II^−/−^ granule neurons, while it was ineffective in WT neurons, thus abolishing the difference between genotypes in both parameters (membrane potential: WT + THIP: −81.44 ± 1.3 mV, *n* = 7 slices, *P* = 0.111 vs. vehicle within genotype; Syn II^−/−^ + THIP: −79.46 ± 1.5 mV, *n* = 8 slices, *P* = 0.047 vs. vehicle within genotype; *P* = 0.325, THIP across genotype; input resistance: WT + THIP: 0.272 ± 0.01 GΩ, *n* = 7 slices, *P* = 0.808 vs. vehicle within genotype; Syn II^−/−^ + THIP: 0.294 ± 0.01 GΩ, *n* = 8 slices, *P* = 0.035 vs. vehicle within genotype; *P* = 0.388, THIP across genotype; two-way ANOVA followed by the Bonferroni\'s post hoc test; Fig. [4](#BHU141F4){ref-type="fig"}*d*,*e*).

Rescue of Tonic Inhibition by THIP Ameliorates Epileptogenic Activity in Cortico-hippocampal Slices From Syn II^−/−^ Mice {#s3d}
-------------------------------------------------------------------------------------------------------------------------

We next investigated the effects of THIP-induced enhancement of tonic inhibition on the epileptiform activity in the cortico-hippocampal network using a high-resolution microelectrode array ([@BHU141C27]). Approximately 5% of untreated acute cortico-hippocampal slices from symptomatic Syn II^−/−^ mice showed spontaneous epileptic-like activity that was never observed in WT slices from age-matched mice (not shown). Quantifiable seizure-like activity in vitro was reproducibly obtained by treating slices with the K^+^ channel blocker 4-AP (100 μM) ([@BHU141C2]; Figs [5](#BHU141F5){ref-type="fig"} and [6](#BHU141F6){ref-type="fig"}). In both genotypes, acute treatment with 4-AP led to the generation of I-IC activity consisting of brief (\<200 ms) and synchronous field potential discharges (Fig. [5](#BHU141F5){ref-type="fig"}*a*,*b*) and long-lasting ictal (IC) activity originating in the rhinal cortices and propagating to the hippocampus (Fig. [6](#BHU141F6){ref-type="fig"}*a*--*d*). The percentage of slices exhibiting IC events was significantly higher in Syn II^−/−^ than in WT slices (*P* = 0.014, *χ*^2^ test with Yates correction) (Fig. [6](#BHU141F6){ref-type="fig"}*a*) and also spread over a wider area in the rhinal cortices (Fig. [6](#BHU141F6){ref-type="fig"}*c*,*e*; WT: 407.9 ± 64.03 electrode pixels, *n* = 10 slices; Syn II^−/−^: 910.6 ± 83.72 electrode pixels, *n* = 13; *P* = 0.0002 across genotype, two-way ANOVA followed by the Bonferroni\'s post hoc test). The frequency of I-IC events (Fig. [5](#BHU141F5){ref-type="fig"}*c*; WT: 0.0224 ± 0.002 Hz and Syn II^−/−^: 0.031 ± 0.002 Hz, *n* = 16 slices/genotype, *P* = 0.013 across genotype, two-way ANOVA followed by the Bonferroni\'s post hoc test) and also the frequency of IC discharges (Fig. [6](#BHU141F6){ref-type="fig"}*f*; WT: 0.0021 ± 0.0005 Hz, *n* = 10 slices; Syn II^−/−^: 0.0040 ± 0.0005 Hz, *n* = 13; *P* = 0.040 across genotype, two-way ANOVA followed by the Bonferroni\'s post hoc test) were all significantly higher in Syn II^−/−^ than in WT slices Figure 5.THIP reduces the I-IC epileptiform activity in acute slices from Syn II^−/−^ mice. (*a*) Raster plots depicting I-IC activities induced by 100 μM 4-AP and recorded over the entire 4096 electrode field in WT (black frame) and Syn II^−/−^ (gray frame) slices before and after THIP treatment. Note the reduction in the frequency of I-IC events induced by THIP in the Syn II^−/−^ networks. (*b*) Representative traces showing 4-AP-induced I-IC activities in the EC and DG of WT and Syn II^−/−^ slices before and after the administration of 1 μM THIP. Traces are taken from one representative electrode per area. (*c*) The application of 1 μM THIP reduces the increased frequency of I-IC events in Syn II^−/−^ slices to WT levels. \**P* \< 0.05 across genotype; ^++^*P* \< 0.01, effect of treatment within genotype; two-way ANOVA followed by the Bonferroni\'s post hoc test. Figure 6.THIP rescues the epileptic-like IC activity in acute brain slices from Syn II^−/−^ mice. (*a*) Occurrence of 4-AP-induced IC events in WT and Syn II^−/−^ slices (*P* = 0.014, *χ*^2^ test with Yates correction). (*b* and *c*) Representative traces of IC activity induced by 100 μM 4-AP in the EC of WT and Syn II^−/−^ slices before and after the administration of 1 μM THIP (*b*) and its regional distribution in the hippocampus and rhinal cortices (*c*) calculated from APS-MEA recordings (color-coded mean firing rate recorded from each 40-μm pixel electrode; see Materials and Methods). (*d*) Raster plots depicting highly synchronized IC activities recorded over the entire 4096 electrode field in WT (black frame) and Syn II^−/−^ (gray frame) slices before and after THIP treatment. Note the reduction in the frequency induced by THIP in the Syn II^−/−^ slices. (*e* and *f*) Bath application of 1 μM THIP reduces the epileptic area (*e*) and the increased frequency of IC events (*f*) in Syn II^−/−^ slices to WT levels. \**P* \< 0.05; \*\*\**P* \< 0.001 across genotype, ^+^*P* \< 0.05, ^++^*P* \< 0.01, effect of treatment within genotype; two-way ANOVA followed by Bonferroni\'s post hoc test. DG, dentate gyrus; CA3, cornu ammonis 3; CA1, cornu ammonis 1; EC, entorhinal cortex; PC, perirhinal cortex.

An increase in tonic inhibition by acute administration of THIP normalized the epileptic phenotype of Syn II^−/−^ slices treated with 4-AP. In Syn II^−/−^ slices, THIP (1 μM) significantly decreased: (1) The frequency of I-IC events (Fig. [5](#BHU141F5){ref-type="fig"}*a*--*c*; WT + THIP: 0.0224 ± 0.002 Hz, *P* = 0.940 vs. vehicle within genotype; Syn II^−/−^ + THIP: 0.024 ± 0.002 Hz, *P* = 0.042 vs. vehicle within genotype; *P* = 0.219, THIP effect across genotype, two-way ANOVA followed by the Bonferroni\'s post hoc test); (2) the active spread area of IC events (Fig. [6](#BHU141F6){ref-type="fig"}*c*,*e*; WT + THIP: 451.2 ± 73.51 electrode pixels, *P* = 0.727 vs. vehicle within genotype; Syn II^−/−^ + THIP: 744.2 ± 89.76 electrode pixels, *P* = 0.001 vs. vehicle within genotype; *P* = 0.024, THIP across genotype, two-way ANOVA followed by the Bonferroni\'s post hoc test); and (3) the frequency of IC discharges (Fig. [6](#BHU141F6){ref-type="fig"}*d*,*f*; WT + THIP: 0.0022 ± 0.0005 Hz, *P* = 0.798 vs. vehicle within genotype; Syn II^−/−^ + THIP: 0.0020 ± 0.0001 Hz, *P* = 0.031 vs. vehicle within genotype; *P* = 0.790, THIP across genotype; two-way ANOVA followed by the Bonferroni\'s post hoc test). Interestingly, the acute treatment with THIP markedly decreased both I-IC and IC activities in Syn II^−/−^ slices lacking endogenous tonic inhibition by bringing them to WT levels, while it had no detectable effects on I-IC frequency, IC spread, or IC frequency in WT slices bearing physiological levels of tonic inhibition.

In Vivo Rescue of Tonic Inhibition by THIP Reverts the Epileptic Phenotype of Syn II^−/−^ Mice {#s3e}
----------------------------------------------------------------------------------------------

Syn II^−/−^ mice are generally healthy and have a normal life span. However, after 2 months of age, they develop seizures that, rarely spontaneous, are triggered by novel stimuli such as handling of the cage and/or the mouse ([@BHU141C15]; [@BHU141C19]). Based on the above results, we tested whether boosting tonic inhibition by in vivo THIP administration had any effects on the propensity and severity of evoked seizures in Syn II^−/−^ mice. Four- to 8-month-old epileptic Syn II^−/−^ mice were subcutaneously implanted with osmotic minipumps filled with either vehicle or THIP to achieve a subchronic treatment for 1 week at dose equivalent to an effective cerebral concentration of 0.5--1 μM ([@BHU141C16]). Seizures were systematically triggered by moving the animal from its cage to an adjacent cage before and at various times after the onset of the treatment and a seizure score was given. We started with all the mice having the highest seizure score (6), which represent a tonic--clonic seizure. Owing to the adaptive characteristic of seizures in Syn KO mice ([@BHU141C19]), only one provocation for each animal was performed at the stated time points.

Interestingly, 1-week treatment with THIP rescues the evoked seizures in Syn II^−/−^ mice with respect to vehicle-treated littermates at 2nd and 7th day of treatment (*n* = 6 mice/group, *P* = 0.006 for THIP-treated and 0.415 for vehicle-treated in both the 2nd and 7th day of treatment; repeated-measures ANOVA followed by the Dunnett\'s post hoc test; Fig. [7](#BHU141F7){ref-type="fig"}*a*,*b*). Virtually, all mice from the initial batch did not present seizure for at least one provocation during the treatment (Fig. [7](#BHU141F7){ref-type="fig"}*a*). The marked amelioration of the epileptic phenotype of Syn II^−/−^ mice was reversible upon discontinuation of the THIP treatment and their seizure propensity recovered to the pre-treatment level 6 weeks after the treatment. One mouse per each group was still seizure-free after 6 weeks, probably due to the habituation with the handling protocol. No effects of the THIP treatment were detected on the animals\' locomotor behavior evaluated in an open field in terms of distance covered, number of entries in the central area, and time spent in the central area (Fig. [7](#BHU141F7){ref-type="fig"}*c*--*f*). Figure 7.THIP rescues the epileptic seizures of Syn II^−/−^ mice. (*a*) Experimental protocol of 1-week minipump treatment with THIP (2.5 mg/kg) or vehicle depicting the occurrence (red squares) of evoked seizures in Syn II^−/−^ mice treated with either vehicle or THIP. (*b*) Seizure score (0--7; see Materials and Methods) of Syn II^−/−^ mice tested before, in the second and seventh day and after the treatment with vehicle (black) or THIP (red). Means ± SEM of the seizure scores are shown. (*c*) Scheme of the gray Plexiglas open-field chamber with the central area (dotted line). (*d*--*f*) Histograms of total covered distance (*d*), number of entrances in the central part (*e*), and time spent in the central part (*f*) by Syn II^−/−^ mice treated with either vehicle (black) or THIP (red). Each dot represents an individual mouse. Open-field experiments were performed on the seventh day of treatment. \*\**P* \< 0.01; one-way ANOVA for repeated measures followed by the Dunnett\'s post hoc test.

Discussion {#s4}
==========

Several mutations in presynaptic proteins have been associated with seizures in human and animal models, but the synaptic mechanisms by which these mutations lead to network hyperexcitability are poorly understood. Our results show that the lack of a presynaptic protein, Syn II, leads to a loss of the tonic inhibitory current, an efficient mean by which networks control their excitability. Tonic inhibition relies on the stimulation of extrasynaptic GABA~A~ receptors by GABA spilled over from inhibitory synapses and diffused through the extracellular volume. Evoked GABA release occurs in two modalities: Time-locked synchronous release mediated by a low-affinity/fast-kinetics Ca^2+^-sensor and delayed asynchronous release linked to a high-affinity/slow-kinetics Ca^2+^-sensor. Asynchronous release, already present in the response to single stimuli, becomes predominant at high stimulation frequencies and can last for hundreds of milliseconds ([@BHU141C1]).

To unravel the link between GABA release and the generation of tonic inhibition, we used high-frequency stimulation to boost asynchronous release in WT and SynII^−/−^ mice, a model of genetic epilepsy that was recently shown to specifically lack asynchronous GABA release in the DG of the hippocampus ([@BHU141C47]). The results demonstrate a tight and causal link between asynchronous GABA release and tonic inhibition. We found that the dramatic decrease in asynchronous GABA release is responsible for the virtual loss of tonic inhibition in the hippocampus of Syn II^−/−^ mice, resulting in hyperexcitability and epileptogenesis. Boosting asynchronous release in WT slices with a 40-Hz tetanic stimulation significantly decreased the excitability of granule neurons after the train, with a time course compatible with the diffusion of asynchronously released GABA to act at extrasynaptic receptors. Notably, the role of asynchronous GABA release in the generation of the tonic GABA current was further demonstrated in Syn II^−/−^ slices that are unable to respond to the tetanus with asynchronous GABA release and, accordingly, do not show any reduction in excitability after the tetanus. The reduction in the AP frequency induced by the delayed asynchronous GABA release in WT neurons was caused by changes in the input resistance, but not in the threshold of AP initiation of the respective neurons, thus mimicking the functional effects of tonic inhibition on excitability.

Such a link between asynchronous release and tonic inhibition could play an important physiological role in the control of network excitability. Being strongly frequency-dependent, asynchronous GABA release can provide an inhibitory tuning whose efficacy increases with the frequency of presynaptic activity ([@BHU141C37]; [@BHU141C3]; [@BHU141C66]; [@BHU141C10]). Computational studies have also proposed that the inhibitory asynchronous release is able to change the postsynaptic gain for a relatively prolonged period after presynaptic activity has subsided ([@BHU141C66]), but a direct proof for this functional role has remained elusive. Importantly, recent results have confirmed the existence of asynchronous GABA release in both rat and human fast-spiking inhibitory neurons ([@BHU141C20]; [@BHU141C39]) and proposed its involvement in the desynchronization of neural networks ([@BHU141C46]). In both human epileptic tissue and a rat model of epilepsy, asynchronous release is increased in fast-spiking neurons and appears to play a protective role in the regulation of epileptiform activities ([@BHU141C20]; [@BHU141C39]). Why asynchronous, and not synchronous, release provides the major contribution to the tonic inhibitory current? The absence of asynchronous release in the DG of Syn II^−/−^ mice, in which inhibitory transmission is characterized by increased phasic and loss of tonic inhibitory current, unambiguously demonstrates the pivotal role of this GABA release mode in the generation of tonic inhibition. It is possible that asynchronously released GABA is less susceptible of reuptake, more prone to diffusion in the extrasynaptic volume and undergoes temporal summation due to its slow kinetics.

We recently reported that a marked excitatory/inhibitory imbalance and loss of tonic inhibition precedes the appearance of the epileptic phenotype and further proceeds during epileptogenesis in the CA1 region of the hippocampus of synapsin triple knockout mice (Syn I,II,III^−/−^) ([@BHU141C22]). Such hyperexcitability was associated with I-IC and IC discharges occurring both spontaneously and in response to 4-AP ([@BHU141C7a]). In the DG of single Syn II^−/−^ mice, we found a similar hyperexcitability at both single granule cell level and network level that were accompanied by a similar marked loss in tonic inhibition. This indicates that the specific loss of the Syn II isoform recapitulates the decrease in tonic inhibition observed in Syn I,II,III^−/−^ ([@BHU141C22]). Also, it seems that the action of Syn II on the DG circuitry may be time and cell-dependent. For example, while here we report an increase firing of granule cells, granule cell firing is normal in the presymptomatic phase of SynII^−/−^ mice; moreover, the other principal excitatory neurons of the DG, the hilar mossy cells, present hypoexcitability in both presymptomatic and symptomatic stages ([@BHU141C65]). However, the latter reduced excitability of mossy cells will eventually lead to a decreased feed-forward inhibition onto granule cells ([@BHU141C65]), suggesting that the overall excitation/inhibition imbalance is intimately connected to the circuitry, regardless of the differential effect on the activity of specific neuronal populations. The developmental regulation of the tonic GABA~A~ conductance over the first postnatal weeks may be one other explanation for the lack of seizures in young Syn II^−/−^. Indeed, some studies reported that the tonic inhibitory current increases with age in cerebellar granule neurons, dentate granule cells, and relay neurons of hypothalamus (see [@BHU141C8], for review). Another study reports a decrease in the total tonic current in the adult DG granule cells, but accompanied by an increase in the GABA~A~ δ-subunit-mediated component ([@BHU141C38]), consistent with an increased expression of δ-subunit in the adult hippocampus ([@BHU141C41]). Moreover, the expression of synapsins is developmentally regulated, and Syn II slowly and steadily increases its expression level after birth to reach a plateau "adult" level only alter 1--2 months ([@BHU141C6]). We may speculate that both the tonic inhibition and the expression of Syn II in key regions controlling network excitability and seizure development, such as the DG, play a minor role at younger ages than they do in the adulthood, thus explaining the late appearance of the epileptic phenotype of Syn II^−/−^ mice.

Tonic inhibition is often decreased in epilepsy, depending on the cellular targets and the type of epilepsy ([@BHU141C67]). Both tonic inhibition and asynchronous GABA release are known to modulate the input--output behavior of single neurons and have a protective role in epilepsy ([@BHU141C39]; [@BHU141C67]). Thus, the causal relationship between these 2 trans-synaptic inhibitory mechanisms not only extends our knowledge on the physiological regulation of network excitability, but can also open the path to new therapeutic strategies. The main therapeutic approaches to increase tonic inhibition are either to target the specific GABA~A~ receptor subtypes that mediate it or to increase the extracellular GABA concentrations (e.g., with the antiepileptic drug tiagabine or vigabatrine) ([@BHU141C67]).

As the primary defect in Syn II^−/−^ and Syn I,II,III^−/−^ mice seems to be an impairment of GABA release and tonic inhibition, while synaptic and extrasynaptic GABA~A~ receptors are not affected ([@BHU141C22]), we attempted to rescue the epileptic phenotype in vitro and in vivo, by selectively enhancing tonic inhibition. So far, it has been impossible to target and specifically correct asynchronous GABA release and the classical way to enhance asynchronous release by replacing extracellular Ca^2+^ with Sr^2+^ cannot distinguish between excitatory and inhibitory transmission ([@BHU141C32]; [@BHU141C1]; [@BHU141C71], [@BHU141C72]). Thus, to specifically enhance tonic inhibition, we used the selective agonist of extrasynaptic GABA~A~ receptors, THIP. Interestingly, a drug similar to THIP acting on the δ subunit-containing GABA~A~ receptors, the synthetic neurosteroid ganaxolone, has recently entered clinical trial for the treatment of epilepsy ([@BHU141C5]).

The effective rescue of the seizure phenotype in Syn II^−/−^ mice after stimulation of δ subunit-containing GABA~A~ receptors by THIP demonstrates a potential applicability of this treatment to the forms of epilepsy associated with an impaired tonic inhibition. Extrasynaptic GABA receptors are localized a few micrometers away from the synapse and possess an unusually high affinity for GABA ([@BHU141C54]; [@BHU141C53]; [@BHU141C51]). Activation of these receptors accounts for an inhibitory charge approximately 4--5 times higher than the charge obtained by the summation of phasic inhibition ([@BHU141C51]). The importance of the tonic inhibitory conductance mediated by δ subunit-containing GABA~A~ receptors is emphasized by the hyperexcitability and epileptic phenotype of δ^−/−^ mice ([@BHU141C64]) and by the association of polymorphisms in GABA~A~ δ subunits in humans with familial generalized epilepsies ([@BHU141C18]). Since the δ subunit of GABA~A~ receptors is regulated by endogenous neurosteroids ([@BHU141C26]), this class of substances may also have new potential clinical applications in epilepsy.

An important question is whether the same mechanisms can be found in mice or patients displaying mutations on other presynaptic proteins involved in epilepsy and seizures. Syn II changes the dynamics of GABA release by interacting with presynaptic Ca^2+^ channels, and all the proteins whose mutations have been found in epileptic patients are connected with the Ca^2+^-dependent release. Munc 18-1 interacts with syntaxins ([@BHU141C36]), SNARE proteins that regulate SV exocytosis, and the mutants of Munc 18-1 alter the kinetics of neurotransmitter release ([@BHU141C13]; [@BHU141C9]). Moreover, an open mutation of Syntaxin-1B leads to generalized seizures and subsequent death at 3 months in mice ([@BHU141C29]). Neurexin 1 is controlling the coupling of Ca^2+^ channels with the presynaptic machinery ([@BHU141C49]). SV2A regulates the Ca^2+^-dependent SV exocytosis ([@BHU141C70]) and interacts with synaptotagmins ([@BHU141C62]), presynaptic Ca^2+^-sensors involved in changing the ratio between synchronous and asynchronous release ([@BHU141C56]; [@BHU141C69]). Thus, alterations in the release machinery that lead to changes in the kinetics of neurotransmitter release may be connected with network hyperexcitability possibly through a change in tonic inhibition, as we propose here. However, additional studies based on other presynaptic proteins involved in the regulation of release dynamics and whose mutations lead to seizures are required to establish if this is a general mechanisms of regulation of neuronal excitability.
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